RIP2 kinase inhibitor 1

• CAT Number: I001634
• CAS Number: 1423186-80-4
• Molecular Formula: C21H22N4O4S2
• Molecular Weight: 458.55
• Purity: ≥95%
• Target: RIP kinase
• Solubility: DMSO: ≥ 32 mg/mL
• Storage: Store at RT

RIP2 kinase inhibitor 1(CAT: I001634) is a small molecule compound that acts as an inhibitor of receptor-interacting protein kinase 2 (RIP2). RIP2, also known as RIPK2, is an intracellular serine/threonine kinase involved in innate immune signaling pathways, particularly in the regulation of inflammatory responses. By inhibiting RIP2 kinase activity, RIP2 kinase inhibitor 1 can modulate immune signaling and potentially attenuate excessive inflammatory responses. This compound has shown promise as a therapeutic target for inflammatory and autoimmune diseases. Further research is being conducted to explore its pharmacological properties and therapeutic applications.

Reference

[1]. Linda N. Casillas, et al. Prodrugs of amino quinazoline kinase inhibitor. PCT Int. Appl. (2014), WO 2014043446 A1 20140320.